Philip Morris (PM) Stock Forecast & Price Target

Philip Morris Intl is attractive because it combines resilient combustible pricing power with a rapidly scaling smoke-free portfolio, allowing the company to post revenue and EPS beats even while reinvesting heavily in growth. Its international franchise still generates the bulk of sales and operating profit, while IQOS and ZYN deepen the mix shift toward reduced-risk products, which were 41.5% of revenue as of 2025, supporting stronger margins and a lower-risk long-term earnings profile. Despite elevated U.S. ZYN spending and some near-term margin pressure, management’s reiterated 2026-2028 targets, strong free cash flow, ~2.4x net debt leverage, and a 3% dividend yield suggest durable financial strength and room for continued shareholder returns.

Philip Morris Intl is vulnerable to IQOS losing share and to intensifying competition in U.S. nicotine pouches, which could sharply slow revenue growth and pressure gross margin and earnings. Its combustible volumes may decline faster than pricing can offset, leading to revenue declines and margin contraction despite the company’s broad reduced-risk portfolio. Regulatory risk also weighs on the outlook, as a longer-than-expected IQOS PMTA process and unforeseen FDA compliance hurdles could disrupt operations and deepen downside to revenue, margins, and the trading multiple.